Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析

◆英語タイトル:Actinium Pharmaceuticals Inc (ATNM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH127755FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Actinium Pharmaceuticals Inc (Actinium), formerly Cactus Ventures Inc, is a biopharmaceutical company. It develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company’s pipeline products include Iomab-B for hematopoietic stem cell transplantation, Iomab-ACT for the treatment of GeneTx and Cell therapy conditioning, and Actimab-M CD33 for Multiple Myeloma. Actinium through its product Iomab-B via the monoclonal antibody BC8, targets CD45, an antigen widely expressed on leukemia and lymphoma cancer cells, B cells and stem cells. The company also offers AWE Technology Platform. It develops products to treat colon, prostrate and brain cancer. ATNM is headquartered in New York, the US.

Actinium Pharmaceuticals Inc Key Recent Developments

Mar 25,2021: Actinium Announces Completion of Enrollment of Second Dose Cohort in Actimab-A Venetoclax Combination Trial for Patients with R/R AML
Mar 03,2021: Actinium announces appointment of Mark Kubik, MBA as chief business officer
Feb 11,2021: Actinium Showcases Targeted Conditioning Program with 2 Oral Presentations Highlighting Iomab-B and Pivotal Phase 3 SIERRA Trial at 2021 Transplantation & Cellular Therapy Annual Meeting
Feb 10,2021: Actinium Announces Participation in BIO CEO & Investor Digital Conference
Jan 13,2021: Astellas announces a research collaboration with Actinium for molecular targeted radiotherapy

This comprehensive SWOT profile of Actinium Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Actinium Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Actinium Pharmaceuticals Inc – Key Information
Actinium Pharmaceuticals Inc – Overview
Actinium Pharmaceuticals Inc – Key Employees
Actinium Pharmaceuticals Inc – Key Employee Biographies
Actinium Pharmaceuticals Inc – Key Operational Heads
Actinium Pharmaceuticals Inc – Major Products and Services
Actinium Pharmaceuticals Inc – History
Actinium Pharmaceuticals Inc – Company Statement
Actinium Pharmaceuticals Inc – Locations And Subsidiaries
Actinium Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Actinium Pharmaceuticals Inc – Business Description
Actinium Pharmaceuticals Inc – Corporate Strategy
Actinium Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Actinium Pharmaceuticals Inc – Strengths
Actinium Pharmaceuticals Inc – Weaknesses
Actinium Pharmaceuticals Inc – Opportunities
Actinium Pharmaceuticals Inc – Threats
Actinium Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Actinium Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Actinium Pharmaceuticals Inc, Key Information
Actinium Pharmaceuticals Inc, Key Ratios
Actinium Pharmaceuticals Inc, Share Data
Actinium Pharmaceuticals Inc, Major Products and Services
Actinium Pharmaceuticals Inc, History
Actinium Pharmaceuticals Inc, Key Employees
Actinium Pharmaceuticals Inc, Key Employee Biographies
Actinium Pharmaceuticals Inc, Key Operational Heads
Actinium Pharmaceuticals Inc, Other Locations
Actinium Pharmaceuticals Inc, Subsidiaries
Actinium Pharmaceuticals Inc, Key Competitors
Actinium Pharmaceuticals Inc, SWOT Analysis
Actinium Pharmaceuticals Inc, Ratios based on current share price
Actinium Pharmaceuticals Inc, Annual Ratios
Actinium Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Constantia Industries AG:企業の戦略的SWOT分析
    Constantia Industries AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Kopran Ltd (KOPRAN):企業の財務・戦略的SWOT分析
    Summary Kopran Ltd (Kopran) is a pharmaceutical company that manufactures finished dosage forms and active pharmaceutical ingredients. The company’s finished dosage form includes tablets, dry powders for oral suspension, capsules, injections and syrups. It offers products in the therapeutic areas of …
  • Coats Group plc:戦略・SWOT・企業財務分析
    Coats Group plc - Strategy, SWOT and Corporate Finance Report Summary Coats Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Engepack Embalagens Sa
    Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report Summary Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ding He Mining Holdings Ltd:企業のM&A・事業提携・投資動向
    Ding He Mining Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ding He Mining Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • WorleyParsons Ltd (WOR):電力:M&Aディール及び事業提携情報
    Summary WorleyParsons Ltd (WorleyParsons) is a provider of professional services. Its services cover the full lifecycle, from creating new assets to sustaining and enhancing operating assets. The company provides integrated solution for deepwater developments with the associated subsea, pipelines, r …
  • Ergomed Plc (ERGO):製薬・医療:M&Aディール及び事業提携情報
    Summary Ergomed Plc (Ergomed), formerly Ergomed Clinical Research Ltd is a drug development and clinical research services provider. The company provides service portfolio such as regulatory and quality management, biostatistics, study management, clinical data management, medical writing, and other …
  • Compania Logistica de Hidrocarburos CLH SA:企業の戦略的SWOT分析
    Compania Logistica de Hidrocarburos CLH SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Hansard Global plc:企業の戦略・SWOT・財務情報
    Hansard Global plc - Strategy, SWOT and Corporate Finance Report Summary Hansard Global plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vectren Corp (VVC):石油・ガス:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • TWC Enterprises Limited:戦略・SWOT・企業財務分析
    TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Software AG:企業の戦略・SWOT・財務分析
    Software AG - Strategy, SWOT and Corporate Finance Report Summary Software AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Integrity Applications Ltd-医療機器分野:企業M&A・提携分析
    Summary Integrity Applications Ltd (Integrity Applications) is a medical device company that designs, develops and commercializes non-invasive glucose monitoring devices. The company offers glucose monitoring devices and is used in ultrasonic, electromagnetic and thermal technologies to (non-invasiv …
  • PNM Resources, Inc.:発電所・企業SWOT分析
    PNM Resources, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Young & Co.’s Brewery plc (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery plc (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Eurofarma Laboratorios SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofarma Laboratorios SA (Eurofarma), formerly Bill Farmaceutica is a pharmaceutical company that manufactures and markets prescription, generic and veterinary drugs. The company offers prescription products such as aerosol ointment, alprazolam, acebrophylline, altiva, ebastel, fluoruracila …
  • MITIE Group Plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group Plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hikal Ltd (HIKAL):企業の財務・戦略的SWOT分析
    Summary Hikal Ltd (Hikal) is a pharmaceutical company that provides custom manufacturing; active ingredients and intermediates. The company provides product portfolio such as antiepileptic, antihistamine, antipsychotic and antilipemic, among others. It offers services such as custom synthesis, contr …
  • QSR Brands (M) Holdings Sdn Bhd:企業の戦略・SWOT・財務情報
    QSR Brands (M) Holdings Sdn Bhd - Strategy, SWOT and Corporate Finance Report Summary QSR Brands (M) Holdings Sdn Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Spherix Inc (SPEX)
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company

◆H&Iグローバルリサーチ株式会社のお客様(例)◆